Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)

"nBackground: Gastric cancer is a common and lethal disease throughout the world. In Iran with 7300 new cases annually, it is the first cause of cancer related death in both sexes. Regarding the high incidence (10.5/100000 individuals) of gastric can­cer and priority of prevalen...

Full description

Bibliographic Details
Main Authors: AA Mehrabian, F Esna-Ashari, H Zham, M Hadizadeh, M Bohlooli, M Khayamzadeh, ME Akbari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-09-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16643.pdf&manuscript_id=16643
id doaj-25cadc7f572e4214b90d4781ddab13b1
record_format Article
spelling doaj-25cadc7f572e4214b90d4781ddab13b12020-12-02T04:06:08ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852010-09-013932731Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)AA MehrabianF Esna-AshariH ZhamM HadizadehM BohlooliM KhayamzadehME Akbari"nBackground: Gastric cancer is a common and lethal disease throughout the world. In Iran with 7300 new cases annually, it is the first cause of cancer related death in both sexes. Regarding the high incidence (10.5/100000 individuals) of gastric can­cer and priority of prevalence index in cancer management, in this study we tried to determine 1, 2-3 and 4-5 year point preva­lence of the disease according to  survival data."nMethod: Survival and incidence data were used for determination of cancer prevalence. Incidence data were extracted from can­cer registry in Iran and survival data were determined in a descriptive study by following up 3439 gastric cancer patients in Cancer Research Center (CRC). 1, 2-3 and 4-5 year prevalence was estimated from incidence rates in different years and the proportion of patients surviving 0.5, 1.5, 2.5, 3.5 and 4.5 years from the time of diagnosis."nResults: patients with survival of 0.5, 1.5, 2.5, 3.5 and 4.5 years from the time of diagnosis were 46.38%, 26 %, 19.36%, 15.47% and 12.8% respectively. The prevalence of 1, 2-3 and 4-5 year was 3392, 3118and 1824 respectively. The cumula­tive 5 year prevalence was 8334 cases."nConclusion: These estimates of the point prevalence of gastric cancer at 1, 2-3 and 4-5 years are applicable to the evalua­tion of initial treatment, clinical follow-up, and point of cure. Therefore 1, 2-3 and 4-5 year point prevalence estimates, are neces­sary in health service planning for gastric cancer management and should be considered by public health managers. http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16643.pdf&manuscript_id=16643Gastric cancerCancer prevalenceStomach cancerIran
collection DOAJ
language English
format Article
sources DOAJ
author AA Mehrabian
F Esna-Ashari
H Zham
M Hadizadeh
M Bohlooli
M Khayamzadeh
ME Akbari
spellingShingle AA Mehrabian
F Esna-Ashari
H Zham
M Hadizadeh
M Bohlooli
M Khayamzadeh
ME Akbari
Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)
Iranian Journal of Public Health
Gastric cancer
Cancer prevalence
Stomach cancer
Iran
author_facet AA Mehrabian
F Esna-Ashari
H Zham
M Hadizadeh
M Bohlooli
M Khayamzadeh
ME Akbari
author_sort AA Mehrabian
title Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)
title_short Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)
title_full Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)
title_fullStr Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)
title_full_unstemmed Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)
title_sort gastric cancer prevalence, according to survival data in iran (national study-2007)
publisher Tehran University of Medical Sciences
series Iranian Journal of Public Health
issn 2251-6085
publishDate 2010-09-01
description "nBackground: Gastric cancer is a common and lethal disease throughout the world. In Iran with 7300 new cases annually, it is the first cause of cancer related death in both sexes. Regarding the high incidence (10.5/100000 individuals) of gastric can­cer and priority of prevalence index in cancer management, in this study we tried to determine 1, 2-3 and 4-5 year point preva­lence of the disease according to  survival data."nMethod: Survival and incidence data were used for determination of cancer prevalence. Incidence data were extracted from can­cer registry in Iran and survival data were determined in a descriptive study by following up 3439 gastric cancer patients in Cancer Research Center (CRC). 1, 2-3 and 4-5 year prevalence was estimated from incidence rates in different years and the proportion of patients surviving 0.5, 1.5, 2.5, 3.5 and 4.5 years from the time of diagnosis."nResults: patients with survival of 0.5, 1.5, 2.5, 3.5 and 4.5 years from the time of diagnosis were 46.38%, 26 %, 19.36%, 15.47% and 12.8% respectively. The prevalence of 1, 2-3 and 4-5 year was 3392, 3118and 1824 respectively. The cumula­tive 5 year prevalence was 8334 cases."nConclusion: These estimates of the point prevalence of gastric cancer at 1, 2-3 and 4-5 years are applicable to the evalua­tion of initial treatment, clinical follow-up, and point of cure. Therefore 1, 2-3 and 4-5 year point prevalence estimates, are neces­sary in health service planning for gastric cancer management and should be considered by public health managers.
topic Gastric cancer
Cancer prevalence
Stomach cancer
Iran
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16643.pdf&manuscript_id=16643
work_keys_str_mv AT aamehrabian gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
AT fesnaashari gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
AT hzham gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
AT mhadizadeh gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
AT mbohlooli gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
AT mkhayamzadeh gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
AT meakbari gastriccancerprevalenceaccordingtosurvivaldatainirannationalstudy2007
_version_ 1724409465704284160